Open

Category Archives: Business

Tamara News  /  Blog  /  Business
11 Sep 2026
US wholesale inflation surge

Wholesale Prices Just Jumped to a Level the Fed Can’t Ignore

Categories Business

US wholesale prices climbed faster than expected in August. The Producer Price Index rose 0.4% for the month and 5.4% from a year earlier. The Bureau of Labor Statistics released the data on September 10. The US wholesale inflation surge complicates the Federal Reserve’s decision just days before its next policy meeting. A hot PPI reading often points to more consumer inflation ahead.

Federal Reserve building, symbol of the policy response to the US wholesale inflation surge

US Wholesale Inflation Surge: What the August Numbers Show

The 5.4% annual increase is up from 4.8% in July. Core PPI, which strips out food and energy, rose 4.6% year over year, above July’s 4.2% pace. Both figures beat most economist forecasts, according to the Bureau of Labor Statistics’ official PPI release. It is the fourth straight month of accelerating wholesale prices, a trend the central bank has been watching closely.

Why Energy Costs Are Driving the Increase

Higher energy costs accounted for much of the monthly gain. Crude oil pushed above $100 a barrel in the days before the report. The spike is tied to ongoing turmoil linked to the conflict in the Middle East. Wholesale diesel prices soared 24.1% in a single month. Diesel feeds into the cost of moving nearly everything sold in the United States, from groceries to construction materials. That is why the spike shows up quickly across the wider producer price basket. Trucking companies typically pass fuel surcharges on to shippers within days, not months, which means the diesel spike is already working its way into freight invoices. Retailers who absorbed early-year cost increases to protect market share say they have less room to do so again if energy prices stay elevated through the fall.

How Markets and the Fed Are Reacting

Interest rate futures moved fast after the release. Traders priced in roughly a 70% probability that the Fed will raise its benchmark rate by 25 basis points in September. That is up from about 61% just a day earlier, according to Yahoo Finance’s coverage of the report. Bond yields ticked higher on the news. Equity traders spent the session weighing stronger producer prices against the risk of a more hawkish Fed.

Oil refinery and shipping infrastructure behind the US wholesale inflation surge

How This Compares to Earlier in 2026

Wholesale inflation has now accelerated for four straight months. It climbed from levels near 4% earlier in the year to 5.4% in August. Economists had expected the pace to level off once early-year tariff effects worked through the supply chain. Instead, the renewed jump in oil and diesel prices reopened the same cost pressures manufacturers and shippers had hoped were fading. Grocery delivery, home construction and freight all depend heavily on diesel-powered transport, so the August spike is expected to show up in a wide range of everyday prices over the next quarter. Some economists caution that a single month of oil-driven inflation should not be read as a permanent trend, since crude prices can fall as quickly as they rose if the underlying Middle East tensions ease.

What the Fed Does From Here

The Federal Open Market Committee meets September 15 and 16. A rate decision is due the afternoon of the 16th. A quarter-point hike would mark the first increase in several meetings, after the Fed held rates steady through the summer. The central bank will also have August’s Consumer Price Index in hand by decision day. That report will show whether wholesale price pressure has already started reaching shoppers. Businesses and households alike are watching for early signs of higher borrowing costs on mortgages, credit cards and business loans.

Frequently Asked Questions

What is the Producer Price Index and why does it matter?

The Producer Price Index tracks prices businesses receive for goods and services before they reach the consumer. A rising PPI often signals that consumer prices will follow within a few months.

How much did US wholesale inflation rise in August 2026?

The PPI rose 0.4% in August and 5.4% from a year earlier, up from 4.8% in July. Core PPI, which excludes food and energy, came in at 4.6% year over year.

Why are oil and diesel prices driving the increase?

Middle East turmoil pushed crude oil above $100 a barrel the week before the report. Wholesale diesel prices jumped 24.1% in a single month, feeding directly into transportation and manufacturing costs.

Will the Federal Reserve raise interest rates because of this?

It has made a rate move more likely. Traders priced in roughly a 70% probability of a 25 basis point hike, up from about 61% the day before the report.

When is the Federal Reserve’s next rate decision?

The Federal Open Market Committee meets September 15 and 16, 2026. A decision is expected the afternoon of the 16th.

How does producer inflation affect consumer prices later?

Businesses facing higher wholesale costs typically raise prices for retailers and consumers within one to three months. A sharp PPI reading often signals where consumer inflation is headed next.

For more on how central banks are responding to this year’s inflation pressure, see Tamara News’ coverage of the Bank of England’s September vote and the OPEC+ decision on October oil output. Companies bracing for the Fed’s move are previewed in our September earnings week preview.

Sources

10 Sep 2026
Biotech laboratory setting representing the Ultragenyx Angelman trial failure story

A Biotech Stock Lost Nearly Half Its Value in One Day — Here’s Why

Categories Business

Shares of Ultragenyx Pharmaceutical plunged more than 46% after the company reported that a Phase 3 trial of its drug candidate for Angelman syndrome failed to meet its primary endpoint. The drop wiped out a significant portion of the biotech’s market value in a single trading session in early September 2026.

Angelman syndrome is a rare genetic neurological disorder. Ultragenyx had positioned the trial as a key step forward. A success would have delivered one of the first approved treatments targeting the condition’s underlying genetic cause rather than only its symptoms.

The condition typically causes developmental delays, speech impairment and seizures. It stems from a loss of function in a single gene. That is why gene-targeted therapies like the one Ultragenyx tested had drawn significant attention from patient advocacy groups. Families affected by Angelman syndrome had closely followed this trial’s progress over the past several years.

Ultragenyx built its business around rare genetic disorders long before this trial began. The company has brought several approved therapies to market for other rare conditions over the past decade. That track record helped build investor confidence heading into this trial’s results. It makes the scale of this week’s drop notable even by biotech standards.

Markets had priced in meaningful future revenue from this program ahead of the readout. The scale of the stock’s decline suggests investors read the missed endpoint as a clear setback rather than a mixed or ambiguous result. A trial that had come close to its goal typically produces a smaller, more contested market reaction than this one did.

What the Ultragenyx Angelman trial failure means

Researchers designed the Phase 3 trial to test whether the drug candidate produced measurable improvement against a specific clinical endpoint tied to Angelman syndrome symptoms. The trial did not achieve that primary endpoint, according to the company’s own disclosure. That kind of result typically forces a pharmaceutical company to choose a path. It can redesign its development program, pursue a narrower indication, or discontinue the candidate altogether.

Medicine vials in a laboratory setting representing the Ultragenyx Angelman trial failure

Biotech stocks routinely see sharp single-day drops on trial failures. Investors often price a drug’s entire commercial value into the stock well in advance of pivotal trial results. A negative readout can then erase most of the anticipated future revenue in one announcement.

Why rare disease trials carry this much risk

Angelman syndrome affects a small patient population, which makes recruiting large enough trial cohorts statistically challenging. Rare disease drug development has attracted growing investment in recent years, mainly because successful therapies can command premium pricing. That same rarity raises the risk that a single trial’s design or population will not generate a clear result.

Ultragenyx has other programs in its pipeline targeting different rare genetic conditions. The company’s broader business will depend on how those separate programs perform, independent of this specific setback.

How investors and patients are likely to respond

For shareholders, the stock’s decline reflects a swift repricing of the company’s near-term prospects rather than a judgment on Ultragenyx’s other pipeline assets. Sentiment around a company often suffers broadly following a high-profile Phase 3 miss, even when other programs remain unaffected. For patients and families affected by Angelman syndrome, the result is a setback in the search for a disease-modifying treatment. It does not necessarily end research in the field, since other companies and academic groups continue separate work on the condition.

Ultragenyx has not yet detailed whether it will pursue additional analysis of the trial data, attempt a follow-up study with a revised design, or discontinue the program entirely.

What the trial data showed on secondary measures

Pharmaceutical companies often look past a missed primary endpoint to see whether secondary measures still show a treatment signal worth pursuing. Ultragenyx has not yet published a detailed breakdown of secondary endpoint results from this trial. Analysts covering the company say that data will likely shape whether Ultragenyx pursues a redesigned study or moves on entirely. Similar rare disease trials have occasionally found a narrower patient subgroup that responded better than the overall study population, which can support a revised regulatory pathway in some cases.

Whether that pattern holds here remains unknown until Ultragenyx releases fuller data, which the company has not yet scheduled.

What happens next for the drug program

Companies facing a missed primary endpoint typically spend weeks reviewing secondary endpoint data and subgroup analyses before deciding on a path forward. Regulatory conversations with agencies like the FDA often follow before any public announcement of next steps. Investors should expect Ultragenyx to provide further detail in its next quarterly earnings update, or in a dedicated announcement once the internal review concludes.

The broader rare disease drug development sector is likely to watch closely. A Phase 3 miss on a closely-tracked program can influence how much capital flows toward similarly structured trials in adjacent rare conditions.

Questions about the trial and stock drop

  • What condition was the drug targeting? Angelman syndrome, a rare genetic neurological disorder.
  • How much did the stock fall? Ultragenyx shares plunged more than 46% following the announcement.
  • Did the trial meet its goal? No, the Phase 3 trial did not achieve its primary endpoint.
  • Is the drug program discontinued? The company has not confirmed whether it will discontinue, redesign, or continue the program.
  • Does this affect Ultragenyx’s other drugs? Not directly, though investor sentiment toward the company broadly may be affected.
  • Are other companies researching Angelman syndrome treatments? Yes, other companies and academic groups continue separate research into the condition.

Related coverage on Tamara News

See our coverage of September’s major class action settlements, GitLab’s earnings surge, and Broadcom’s Q4 revenue forecast.

Sources

  • CNBC — Stock market news for Sept. 4, 2026, covering major earnings movers. cnbc.com
  • ii.co.uk — US earnings season Q2 2026 roundup. ii.co.uk

10 Sep 2026
Bank building facade representing the WaFd EverBank reverse merger

A $3.9 Billion Bank Deal Just Rewrote the West Coast Banking Map

Categories Business

WaFd, a Pacific Northwest bank holding company, has entered into a $3.9 billion reverse merger with EverBank Financial Corp. The deal, announced September 8, 2026, will reshape the combined company’s footprint across the western and southeastern United States.

In a reverse merger, the smaller or less-publicly-traded party often ends up governing the resulting entity’s structure. That happens even though the larger partner’s brand may carry forward. WaFd and EverBank are still working out the exact governance and branding details as regulatory filings proceed.

WaFd traces its roots back more than a century as a Seattle-based thrift institution before expanding into a full-service regional bank. EverBank built its national presence primarily through digital banking products aimed at customers outside its traditional southeastern footprint. Combining the two brings together very different growth strategies under one holding structure.

WaFd operates branches across several Western states, giving it a physical retail presence that EverBank’s largely digital model does not replicate. Analysts point to that combination of branch banking and digital scale when explaining the strategic logic behind the deal. It goes beyond the raw dollar figures involved.

Bank executives on both sides have framed the deal publicly as complementary rather than defensive. Neither company has described itself as struggling ahead of the merger. That framing matters, since regulators and shareholders often scrutinize distressed mergers more closely than deals struck from a position of relative strength.

What the WaFd EverBank reverse merger actually changes

The deal combines WaFd’s West Coast retail and commercial banking footprint with EverBank’s national digital banking operations and southeastern presence. Together, the two create a combined institution with a broader geographic reach than either company had independently. The $3.9 billion valuation reflects EverBank’s scale as a digitally-focused bank that has grown its national deposit base in recent years.

Bank headquarters building representing the WaFd EverBank reverse merger deal

Bank mergers of this size typically require sign-off from federal banking regulators. Those include the Federal Reserve and the Office of the Comptroller of the Currency. That process can take months. It occasionally results in conditions attached to approval, such as divestitures in overlapping markets.

Why banks are consolidating again in 2026

The WaFd-EverBank deal is part of a broader wave of regional bank consolidation that has picked up through 2026. Mid-sized banks are weighing the cost of standalone technology investment and regulatory compliance against the scale advantages of combining with a partner. Regional banks in particular have faced pressure to match the digital banking capabilities of larger national players.

Analysts tracking the sector point to rising compliance costs and thin net interest margins as recurring drivers behind similar tie-ups this year. WaFd has not fully detailed the specific financial terms behind its rationale for this transaction in public filings as of early September.

What customers should expect

Bank mergers typically do not change existing account terms immediately. Customers of both institutions should expect continuity of service through the transition period, which regulatory review alone is likely to extend well into 2027. WaFd has completed prior acquisitions with limited disruption to existing depositors, maintaining separate branding for a period before full integration.

Employees and depositors will likely receive formal notices as the transaction moves through regulatory review. That notice process is standard practice for deals of this size under US banking law.

How this deal compares with other 2026 bank mergers

Regional banking has seen a wave of tie-ups this year, and the WaFd-EverBank transaction is among the largest by dollar value. Several smaller regional players have pursued similar combinations, citing the same pressures: rising technology spend, thin margins and competition from digitally-native banking apps. Industry observers say the pace of consolidation could continue into 2027 if interest rates stay elevated and margin pressure persists. Community banking advocates have raised concerns that consolidation reduces the number of independent local lenders, particularly in smaller markets.

WaFd has not said whether it expects to close any physical branches as part of the integration. That detail typically emerges later in the regulatory review process.

What happens next for the combined bank

The merger now moves into regulatory review, where federal banking agencies will assess competitive overlap, capital adequacy and consumer protection considerations before granting approval. Both companies will need shareholder approval in parallel with the regulatory process, a step typically scheduled once filings are further along.

If approved on a typical timeline, the combined institution would likely complete integration sometime in 2027. That estimate is based on how comparable regional bank mergers have played out in recent years.

Questions about the WaFd-EverBank deal

  • How much is the deal worth? The transaction is valued at $3.9 billion.
  • When was it announced? September 8, 2026.
  • What is a reverse merger? A deal structure where the surviving legal entity is not always the larger or more well-known of the two combining companies.
  • Will customer accounts change immediately? No, existing account terms typically remain unchanged during the transition period.
  • Does the deal still need approval? Yes, federal banking regulators and shareholders of both companies must approve the transaction.
  • When might the merger close? Based on comparable deals, completion in 2027 is a reasonable expectation, pending regulatory review.

Related coverage on Tamara News

See our coverage of Palo Alto Networks’ acquisition spree, the Bank of Canada’s rate hold decision, and the upcoming Bank of England September vote.

Sources

  • CNBC — Stock market news for Sept. 4, 2026, covering the week’s major acquisitions. cnbc.com
  • Yahoo Finance — Company earnings and deal calendar. finance.yahoo.com

09 Sep 2026
Bank of England September vote

The Bank of England’s Next Vote Could Go Either Way. Here’s the Math

Categories Business

The next Bank of England September vote lands on Thursday, September 17, 2026, at noon London time. It follows a divided vote in July, when three of nine Monetary Policy Committee members wanted a rise to 4.00% while the majority held Bank Rate at 3.75%. That split leaves the September outcome unusually hard to call.

Why the Bank of England September vote is finely balanced

Headline UK inflation has risen from 2.6% to 2.9% since the July meeting, according to the Bank’s own July 2026 monetary policy summary. The Bank’s central projection at that meeting showed CPI inflation peaking around 3.2% in the fourth quarter of 2026, well above the 2% target.

Bank of England September vote
The Bank of England's Next Vote Could Go Either Way. Here's

Crucially, August inflation figures land at 7am on Wednesday, September 16, the morning before the Committee votes. That means members will have two additional Consumer Prices Index readings and two more labour market releases in hand compared with the July meeting, giving fresher data a real chance to move the outcome.

What markets are pricing in

Market-implied probability estimates have varied notably in recent days. Some readings put the probability of no change as high as 90%, while earlier estimates put it closer to 72%, according to analysis from BritSavvy. A market-implied move of roughly 7 basis points above the current 3.75% rate suggests traders see some, but not overwhelming, chance of a hike.

The spread between those estimates itself signals genuine uncertainty. Unlike meetings where a hold or hike is treated as close to certain going in, this decision remains open heading into the final data releases.

The case for holding versus hiking

Policymakers favoring a hold point to the risk that raising rates too aggressively could choke off growth just as inflation pressures show signs of moderating elsewhere in the economy. Those favoring a rise argue that inflation running nearly a full point above target, and rising rather than falling, justifies tighter policy now rather than waiting.

The three dissenting votes in July signal that at least a meaningful minority of the Committee already leans toward tightening. Whether that minority grows depends heavily on what the August inflation print shows.

What to watch before the September vote

The August CPI release on September 16 is the single data point most likely to shift expectations. A reading meaningfully above 2.9% would strengthen the case for a hike. A reading that holds steady or eases would support the majority’s preference to hold.

Labour market data due before the meeting will also factor into the Committee’s thinking. Wage pressure remains a key input into how persistent inflation is likely to prove over the coming year.

Mortgage holders and homebuyers have a direct stake in the outcome too. A hold keeps borrowing costs steady for now, while a surprise hike would raise monthly payments on new and variable-rate mortgages almost immediately.

How this compares with the Fed and ECB

The Bank of England is not alone in facing a close call this month. The U.S. Federal Reserve left rates unchanged for a fifth straight meeting in July, though three officials dissented in favor of a hike. Fed Chair Kevin Warsh flagged persistent underlying inflation at the Jackson Hole symposium in August.

The European Central Bank, by contrast, has held its key rates steady since July with less internal division. Eurosystem staff project headline inflation averaging 3.0% in 2026, broadly similar to the Bank of England’s own outlook.

What sets the UK apart is the size of the dissent. A 6-3 vote signals real disagreement within the Committee, more pronounced than the splits currently visible at the Fed or ECB. That makes the Bank of England September vote this month one of the more closely watched among major central banks.

Currency traders have taken note. Sterling has shown more sensitivity to incoming UK data releases in recent weeks than the dollar or euro have to their own domestic releases, reflecting the market’s uncertainty about which way the September vote will go.

Readers’ questions on the rate decision

When is the next Bank of England September vote?
The Monetary Policy Committee announces its decision on Thursday, September 17, 2026, at noon London time.

What was the outcome of the July meeting?
The Bank held Bank Rate at 3.75% in a divided 6-3 vote, with three members preferring a rise to 4.00%.

What is UK inflation running at now?
Headline CPI inflation has risen from 2.6% to 2.9% since the July decision, with the Bank projecting a peak near 3.2% in Q4 2026.

What data comes out before the decision?
August inflation figures are released at 7am on September 16, the morning before the vote, along with additional labour market data.

Are markets expecting a rate hike?
Estimates vary. Some market-implied probabilities put the chance of no change as high as 90%, while other readings suggest a closer contest.

For related central bank coverage, see our reporting on the Bank of Canada’s rate hold and the latest jobs report and rate-hike odds.

Sources

09 Sep 2026
PayTabs Amazon Payment Services

This $100M Deal Just Created the Biggest Payments Firm in the Middle East

Categories Business

The PayTabs Amazon Payment Services deal, announced this week, will see the Saudi-founded fintech acquire Amazon’s payments business across the Middle East and North Africa in a transaction valued at more than $100 million. The combined company is projected to process over SAR150 billion annually once the deal closes, making it the largest payments infrastructure provider in the region.

What the PayTabs Amazon Payment Services deal includes

Amazon Payment Services, formerly known as PayFort, operates across nine MENA markets and serves more than 3,500 businesses. It supports major global card networks alongside regional payment methods including Mada, Knet and Meeza, according to Fintech Global. Both companies say continuity of service will be a priority during the integration.

PayTabs Amazon Payment Services
This $100M Deal Just Created the Biggest Payments Firm in th

Neither company has disclosed the exact purchase price beyond the more-than-$100-million figure both confirmed. Both boards approved the transaction, though neither side has announced a specific closing date yet.

Why PayTabs wanted this acquisition

This is not PayTabs’ first move to consolidate payments infrastructure in the region. The company purchased the UAE contactless payments firm TAPn’GO in April 2026, and acquired the Turkish social-commerce platform Paymes back in 2022. The Amazon Payment Services deal extends that pattern into a much larger acquisition, according to Payment Expert.

Scale matters in payments infrastructure because processing volume drives negotiating leverage with card networks and banks. Absorbing Amazon’s MENA payments arm gives PayTabs both a larger merchant base and deeper integration with regional payment rails in a single move.

What it means for merchants using either platform

Businesses currently using Amazon Payment Services should expect a transition period as accounts, integrations and support move under PayTabs. Both companies say continuity is a priority, though they have not yet published the practical details of migration.

For merchants weighing payment providers in the region, the deal reduces the number of large independent players, concentrating more processing volume under fewer companies. That trend mirrors consolidation seen in payments markets elsewhere over the past several years.

What the deal still needs to close

Regulatory approvals across the nine markets Amazon Payment Services operates in will likely determine the actual closing timeline. Payments licensing in the Gulf region typically requires central bank sign-off. That process can extend well beyond the announcement-to-close window seen in less regulated sectors.

Watch for formal integration announcements from PayTabs in the coming months. Regulatory filings in individual MENA markets would also help confirm a firm closing date.

Neither company has said whether branding will change once the transition completes, or whether Amazon Payment Services will be folded fully into the PayTabs name. Merchants will likely get more clarity on that question once regulators sign off in the largest markets involved.

How the region’s fintech map is shifting

The MENA payments sector has consolidated rapidly over the past two years. Large regional players have absorbed smaller processors as banks push for fewer, deeper technology partnerships. PayTabs’ latest move fits that pattern, but at a scale larger than its previous acquisitions.

Saudi Arabia’s push toward a cashless economy under its national development plans has fueled much of this activity. Government-backed initiatives have encouraged digital payment adoption across retail, government services and e-commerce. PayTabs, founded in Saudi Arabia, sits close to that policy push.

Amazon’s decision to exit direct ownership of its MENA payments arm also fits a broader pattern. Large global platforms have increasingly preferred to license or outsource regional payment rails rather than operate them directly, especially in markets with complex local licensing regimes.

For competitors, the deal raises the bar. A combined PayTabs-Amazon Payment Services entity processing more than SAR150 billion annually gives it negotiating leverage smaller rivals cannot easily match. Some analysts expect further consolidation among mid-sized regional processors within the next year.

Central banks across the Gulf have generally supported consolidation that strengthens payment security and reliability, provided it does not concentrate too much market share in a single provider. Regulators will likely scrutinize that balance closely as the deal moves toward formal approval.

Frequently asked questions about the PayTabs deal

How much is the PayTabs Amazon Payment Services deal worth?
The deal is valued at more than $100 million, though neither company has publicly disclosed the exact purchase price.

Which markets does Amazon Payment Services operate in?
It operates across nine MENA markets, serving more than 3,500 businesses with support for global card networks and regional payment methods.

Has PayTabs made similar acquisitions before?
Yes. PayTabs acquired UAE contactless payments firm TAPn’GO in April 2026 and Turkish platform Paymes in 2022.

Will merchants using Amazon Payment Services be affected?
Accounts and integrations are expected to transition to PayTabs over time, with both companies stating continuity of service is a priority.

When will the deal officially close?
Neither company has announced a specific closing date publicly. Regulatory approval across multiple MENA markets will likely determine the final timeline.

For more on major technology and payments consolidation this year, see our coverage of the Nvidia-Hugging Face acquisition and Palo Alto Networks’ acquisition spree.

Sources

1 … 17 18 19 20 21 … 27